Hester Biosciences informs about outcome of board meeting

31 Jan 2022 Evaluate
Hester Biosciences has informed that Board of Directors, in their Meeting held today, have approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31 December 2021, as recommended by Audit Committee. It enclosed the approved standalone and consolidated unaudited financial results and limited review reports; Press Release issued in this regard. The Company would be publishing the extract of results in the newspaper as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 11:15 am (IST) and concluded at 11:44 am (IST).

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

2391.05 20.90 (0.88%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.50
Dr. Reddys Lab 1340.80
Cipla 1476.45
Lupin 2160.20
Zydus Lifesciences 972.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.